Sanjeev Redkar is the founder of Apollomics. Apollomics has raised $250M in total funding. Latest round: Series C.
Sanjeev G. Redkar is the Co-Founder and President of Apollomics, a cross-border biotech company focused on oncology that was listed on Nasdaq under the ticker APLM. He holds a PhD in Chemical Engineering from the University of Colorado and previously worked at CBT Pharmaceuticals Inc.
Full founder directory · Investor directory · Company funding database · Fundraising library